search
Back to results

Treatment of Schizophrenia Through Internet-Based Psychoeducation

Primary Purpose

Schizophrenia, Schizoaffective Disorder

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
World Wide Web-Based Psychoeducation
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Schizophrenia

Eligibility Criteria

14 Years - 55 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria DSM-IV diagnosis of schizophrenia or schizoaffective disorder At least 4 hours/week in-person contact with a family member Primary caregiver with a telephone Patient and primary caregiver speak and read English Exclusion Criteria: Enrolled in another clinical trial Evidence of organic brain syndrome Current alcohol or substance abuse that could explain the presenting index psychotic episode DSM-IV diagnosis of psychoactive substance dependency

Sites / Locations

  • University of Pittsburgh Western Psychiatric Institute and Clinic

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
January 7, 2003
Last Updated
June 26, 2014
Sponsor
University of Pittsburgh
Collaborators
National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT00051233
Brief Title
Treatment of Schizophrenia Through Internet-Based Psychoeducation
Official Title
Schizophrenia Patient and Family Continuity of Care
Study Type
Interventional

2. Study Status

Record Verification Date
June 2014
Overall Recruitment Status
Completed
Study Start Date
January 2003 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
January 2005 (undefined)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Pittsburgh
Collaborators
National Institute of Mental Health (NIMH)

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to assess the effectiveness of a Web-based psychoeducational program in helping people with schizophrenia and their families manage the disease.
Detailed Description
This study will provide a comprehensive psychoeducational program which includes education, social support, information, coping strategies, and guidance from mental health, social services, and medical professionals. This study will work to reduce relapse, facilitate patient rehabilitation, decrease family distress, and improve family well being. Patients and their families participate in an in-person Psychoeducational Survival Skills Workshop that is designed to provide patients and their families with basic information about schizophrenia and its treatment. After the workshop, participants are provided with 6 Web-based modules that are designed to increase mental health and schizophrenia knowledge. Patient relapse, family distress, family knowledge of schizophrenia, and data on user's acceptance and utilization are measured to determine the intervention's effectiveness.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia, Schizoaffective Disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (false)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
World Wide Web-Based Psychoeducation

10. Eligibility

Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria DSM-IV diagnosis of schizophrenia or schizoaffective disorder At least 4 hours/week in-person contact with a family member Primary caregiver with a telephone Patient and primary caregiver speak and read English Exclusion Criteria: Enrolled in another clinical trial Evidence of organic brain syndrome Current alcohol or substance abuse that could explain the presenting index psychotic episode DSM-IV diagnosis of psychoactive substance dependency
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Armando J Rotondi
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pittsburgh Western Psychiatric Institute and Clinic
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15261
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Treatment of Schizophrenia Through Internet-Based Psychoeducation

We'll reach out to this number within 24 hrs